Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX.

Oncotarget · 2016 · PMC5341877 · PMID 27634903

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

9.1 months); moreover, the association had a statistically significance for PFS but a strong trend for OS in multivariate analysis.

also in 5,725 other papers

highly significantno p-value reported

In a subgroup analysis of the TRIBE trial, a highly significant correlation of both ETS and DpR with survival parameters (PFS, post progression survival, and OS) was reported in the arm of triplet plus bevacizumab treatment [ 5 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.